Bio-View Ltd (TLV: BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA 29.90
+0.90 (3.10%)
Jan 20, 2025, 11:27 AM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 38.48 million as of January 21, 2025. Its market cap has decreased by -15.71% in one year.
Market Cap
38.48M
Enterprise Value
24.49M
Revenue
34.34M
Ranking
n/a
PE Ratio
49.70
Stock Price
29.90
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 38.48M, a decrease of -35.64%. That is a compound annual growth rate of -2.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 88.56B |
| Danel (Adir Yeoshua) | 2.52B |
| Kamada | 1.50B |
| Bait Bakfar | 1.05B |
| Novolog (Pharm-Up 1966) | 981.60M |
| Ilex Medical | 877.41M |
| BrainsWay | 694.21M |
| SofWave Medical | 596.96M |